Mechanistic insights aid computational short interfering RNA design

被引:58
|
作者
Boese, Q
Leake, D
Reynolds, A
Read, S
Scaringe, SA
Marshall, WS
Khvorova, A
机构
来源
RNA INTERFERENCE | 2005年 / 392卷
关键词
D O I
10.1016/S0076-6879(04)92005-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
RNA interference is widely recognized for its utility as a functional genomics tool. In the absence of reliable target site selection tools, however, the impact of RNA interference (RNAi) may be diminished. The primary determinants of silencing are influenced by highly coordinated RNA-protein interactions that occur throughout the RNAi process, including short interfering RNA (siRNA) binding and unwinding followed by target recognition, cleavage, and subsequent product release. Recently developed strategies for identification of functional siRNAs reveal that thermodynamic and siRNA sequence-specific properties are crucial to predict functional duplexes (Khvorova et al., 2003; Reynolds et al., 2004; Schwarz et al., 2003). Additional assessments of siRNA specificity reveal that more sophisticated sequence comparison tools are also required to minimize potential off-target effects (Jackson et al., 2003; Semizarov et al., 2003). This chapter reviews the biological basis for current computational design tools and how best to utilize and assess their predictive capabilities for selecting functional and specific siRNAs.
引用
收藏
页码:73 / +
页数:25
相关论文
共 50 条
  • [31] 3Si: A computer program for the optimal design of short interfering RNA (siRNA) for gene silencing
    Chen, WP
    Zha, W
    Cox, T
    Zhao, XJ
    Russell, P
    17TH IEEE SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, PROCEEDINGS, 2004, : 335 - 342
  • [32] Preclinical efficacy of Periostin short interfering RNA in pulmonary fibrosis
    Hinneh, J.
    D'Alessandro-Gabazza, C. N.
    Toda, M.
    Yasuma, T.
    Kentaro, F.
    Nishihama, K.
    Kobayashi, T.
    Etsuko, H.
    Gabazza, E.
    Yazunori, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 582 - 582
  • [33] New short interfering RNA-based therapies for glomerulonephritis
    Shimizu, Hideki
    Fujita, Toshiro
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (07) : 407 - 415
  • [35] REQUEST FOR RETRACTION: SHORT INTERFERING RNA (siRNA) AS A NOVEL THERAPEUTIC
    Melendez-Romero, Alirio
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (04) : 305 - 305
  • [36] Formulation approaches to short interfering RNA and MicroRNA: Challenges and implications
    Guzman-Villanueva, Diana
    El-Sherbiny, Ibrahim M.
    Herrera-Ruiz, Dea
    Vlassov, Alexander V.
    Smyth, Hugh D. C.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (11) : 4046 - 4066
  • [37] Silencing the formylpeptide receptor FPR by short-interfering RNA
    Le, YY
    Iribarren, P
    Zhou, Y
    Gong, WH
    Hu, JY
    Zhang, X
    Wang, JM
    MOLECULAR PHARMACOLOGY, 2004, 66 (04) : 1022 - 1028
  • [38] Short Interfering RNA (siRNA)-Based Therapeutics for Cartilage Diseases
    Libo Zhou
    Lee E. Rubin
    Chuanju Liu
    Yupeng Chen
    Regenerative Engineering and Translational Medicine, 2021, 7 : 283 - 290
  • [39] Short interfering RNA in colorectal cancer: is it wise to shoot the messenger?
    Chandramohan, Kiruthiga
    Balan, Devasahayam Jaya
    Devi, Kasi Pandima
    Nabavi, Seyed Fazel
    Reshadat, Sara
    Khayatkashani, Maryam
    Mahmoodifar, Sepideh
    Filosa, Rosanna
    Amirkhalili, Niloufar
    Pishvaei, Soroush
    Sargazi-Aval, Omolbanin
    Nabavi, Seyed Mohammad
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 949
  • [40] Short interfering RNA-mediated gene targeting in the zebrafish
    Dodd, A
    Chambers, SP
    Love, DR
    FEBS LETTERS, 2004, 561 (1-3) : 89 - 93